Plain-English translation of NCT07240519 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether fractional CO2 laser therapy might work as well as—or better than—clobetasol propionate ointment for treating vulvar lichen sclerosus, a chronic inflammatory skin condition that causes itching, pain, and can change the appearance of the vulva. Researchers want to understand how each treatment affects the body's inflammatory response by looking at tissue samples before and after treatment. By comparing these two approaches, doctors hope to find whether laser could be a helpful alternative for patients who cannot tolerate or prefer not to use long-term steroid creams.
The standard treatment (steroid ointment) can cause side effects like skin thinning and fungal infections with prolonged use, and researchers want to know if laser therapy might reduce inflammation and symptoms while avoiding these risks.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the steroid ointment or laser therapy. If you receive the ointment, you'll apply it daily for one month, then gradually reduce frequency over the next two months. If you receive laser, you'll have three treatment sessions spaced four weeks apart, with numbing cream applied beforehand and recovery instructions (like avoiding sex for five days). At the start and three months after completing treatment, small tissue samples (punch biopsies) will be taken from the affected area to measure inflammation. You'll also answer questions about your symptoms, pain, and satisfaction with the treatment throughout the study.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Brazil